Acquired

Comprehend Systems Stock

Comprehend is a technology company with a new class of cloud software to help ClinOps teams continuously improve speed and quality.

Sign up today and learn more about Comprehend Systems Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Comprehend Systems Stock

Comprehend is a technology company with a new class of cloud software to help Clinical Operations continuously improve the speed, efficiency and quality of clinical trials across its portfolio of studies. For the first time, teams are given a single system with powerful data aggregation, monitoring, collaboration and analytic capabilities to actively manage enrollment funnels, patient compliance, data quality and site productivity across systems, studies and sites. The Continuous Quality Solution (CQS) goes beyond traditional site monitoring, giving ClinOps teams and executives portfolio monitoring on their key performance and risk indicators to significantly lower the cost, time and risk to deliver milestones on-time. The most demanding life sciences companies including Merck, AstraZeneca and Astellas, as well as ClinOps innovators such as bluebird bio and Jazz Pharmaceuticals, trust Comprehend CQS to provide the confidence necessary to deliver high-quality clinical trial submissions at a new speed. Comprehend: the speed to quality results. Visit Comprehend at www.comprehend.com.

Funding History

November 2011$1.2M
July 2013$8.5M
August 2014$21.0M
February 2017$15.0M

Management

Chief Revenue Officer

Kevin Kennedy

CMO and Head of Product

Rani Hublou

Founder & CTO

Jud Gardner

Founder and President

Rick Morrison

Investor

Lyon Wong

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo